223 related articles for article (PubMed ID: 26631686)
1. Cerebral Glucose Metabolism Assessment in Rat Models of Alzheimer's Disease: An 18F-FDG-PET Study.
Lu Y; Ren J; Cui S; Chen J; Huang Y; Tang C; Shan B; Nie B; Xinsheng L
Am J Alzheimers Dis Other Demen; 2016 Jun; 31(4):333-40. PubMed ID: 26631686
[TBL] [Abstract][Full Text] [Related]
2. Effects of acupuncture at HT7 on glucose metabolism in a rat model of Alzheimer's disease: an 18F-FDG-PET study.
Lai X; Ren J; Lu Y; Cui S; Chen J; Huang Y; Tang C; Shan B; Nie B
Acupunct Med; 2016 Jun; 34(3):215-22. PubMed ID: 26654890
[TBL] [Abstract][Full Text] [Related]
3. Cerebral Responses to Acupuncture at GV24 and Bilateral GB13 in Rat Models of Alzheimer's Disease.
Cui S; Xu M; Huang J; Wang QM; Lai X; Nie B; Shan B; Luo X; Wong J; Tang C
Behav Neurol; 2018; 2018():8740284. PubMed ID: 29854022
[TBL] [Abstract][Full Text] [Related]
4. The functional neuroanatomy of verbal memory in Alzheimer's disease: [
Staffaroni AM; Melrose RJ; Leskin LP; Riskin-Jones H; Harwood D; Mandelkern M; Sultzer DL
J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
[TBL] [Abstract][Full Text] [Related]
5. Biological characters of [18F]O-FEt-PIB in a rat model of Alzheimer's disease using micro-PET imaging.
Zheng MQ; Yin DZ; Zhang L; Lei B; Cheng DF; Cai HC; Han YJ; Wu MX; Zhang H; Wang J
Acta Pharmacol Sin; 2008 May; 29(5):548-54. PubMed ID: 18430362
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
Alexander GE; Chen K; Pietrini P; Rapoport SI; Reiman EM
Am J Psychiatry; 2002 May; 159(5):738-45. PubMed ID: 11986126
[TBL] [Abstract][Full Text] [Related]
7. Cannabidiol Treatment Improves Glucose Metabolism and Memory in Streptozotocin-Induced Alzheimer's Disease Rat Model: A Proof-of-Concept Study.
de Paula Faria D; Estessi de Souza L; Duran FLS; Buchpiguel CA; Britto LR; Crippa JAS; Filho GB; Real CC
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163003
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.
Liguori C; Chiaravalloti A; Sancesario G; Stefani A; Sancesario GM; Mercuri NB; Schillaci O; Pierantozzi M
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2040-9. PubMed ID: 27221635
[TBL] [Abstract][Full Text] [Related]
9. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
[TBL] [Abstract][Full Text] [Related]
10. [Measurement of regional cerebral metabolism rate of glucose in patients with Alzheimer's disease in different levels of severity].
Xiao SF; Cao QY; Xue HB; Liu YC; Zuo CT; Jiang KD; Zhang MY
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2975-9. PubMed ID: 16324383
[TBL] [Abstract][Full Text] [Related]
11. Voxel-based analysis of Alzheimer's disease PET imaging using a triplet of radiotracers: PIB, FDDNP, and FDG.
Shin J; Lee SY; Kim SJ; Kim SH; Cho SJ; Kim YB
Neuroimage; 2010 Aug; 52(2):488-96. PubMed ID: 20385246
[TBL] [Abstract][Full Text] [Related]
12. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
Hunt A; Schönknecht P; Henze M; Seidl U; Haberkorn U; Schröder J
Psychiatry Res; 2007 Jul; 155(2):147-54. PubMed ID: 17524628
[TBL] [Abstract][Full Text] [Related]
13. Multi-center study on Alzheimer's disease using FDG PET: group and individual analyses.
Yuan X; Shan B; Ma Y; Tian J; Jiang K; Cao Q; Wang R
J Alzheimers Dis; 2010; 19(3):927-35. PubMed ID: 20157248
[TBL] [Abstract][Full Text] [Related]
14. Reduction of Glucose Metabolism in Olfactory Bulb is an Earlier Alzheimer's Disease-related Biomarker in 5XFAD Mice.
Xiao NA; Zhang J; Zhou M; Wei Z; Wu XL; Dai XM; Zhu YG; Chen XC
Chin Med J (Engl); 2015 Aug; 128(16):2220-7. PubMed ID: 26265617
[TBL] [Abstract][Full Text] [Related]
15. [Application of positron emission tomography in evaluation of Alzheimer's disease rat model].
He TT; Zhang JM; Wang RM; Yao SL; Tian JH
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(13):924-7. PubMed ID: 20646515
[TBL] [Abstract][Full Text] [Related]
16. [The comparison of the regional cerebral metabolism rate of glucose in Alzheimer's disease with mild cognitive impairment].
Cao Q; Jiang K; Liu Y; Zhang M; Xiao S; Zuo C; Huang H
Zhonghua Yi Xue Za Zhi; 2002 Dec; 82(23):1613-6. PubMed ID: 12667368
[TBL] [Abstract][Full Text] [Related]
17. Comparability of [
Rodriguez-Vieitez E; Leuzy A; Chiotis K; Saint-Aubert L; Wall A; Nordberg A
J Cereb Blood Flow Metab; 2017 Feb; 37(2):740-749. PubMed ID: 27107028
[TBL] [Abstract][Full Text] [Related]
18. Syndrome-specific patterns of regional cerebral glucose metabolism in posterior cortical atrophy in comparison to dementia with Lewy bodies and Alzheimer's disease--a [F-18]-FDG pet study.
Spehl TS; Hellwig S; Amtage F; Weiller C; Bormann T; Weber WA; Hüll M; Meyer PT; Frings L
J Neuroimaging; 2015; 25(2):281-288. PubMed ID: 24593796
[TBL] [Abstract][Full Text] [Related]
19. Butyrylcholinesterase-knockout reduces fibrillar β-amyloid and conserves
DeBay DR; Reid GA; Macdonald IR; Mawko G; Burrell S; Martin E; Bowen CV; Darvesh S
Brain Res; 2017 Sep; 1671():102-110. PubMed ID: 28729192
[TBL] [Abstract][Full Text] [Related]
20. Postoperative alteration of cerebral glucose metabolism in mesial temporal lobe epilepsy.
Joo EY; Hong SB; Han HJ; Tae WS; Kim JH; Han SJ; Seo DW; Lee KH; Hong SC; Lee M; Kim S; Kim BT
Brain; 2005 Aug; 128(Pt 8):1802-10. PubMed ID: 15872014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
